Crinetics Pharmaceuticals Europe GmbH

Pharmaceuticals · Zug, Zug

Crinetics Pharmaceuticals Europe GmbH is a Swiss pharmaceuticals company based in Zug, Canton of Zug, listed in the Swiss commercial register since 2024 (UID CHE-481.892.698).

Legal nameCrinetics Pharmaceuticals Europe GmbH
AddressGubelstrasse, Zug
UID / VATCHE-481.892.698
Legal form · StatusGmbH · Active · 2024

Board members & signatories

  • Samer Saadeh — Geschäftsführer
  • Isabel Kalofonos — Geschäftsführer
  • Jeff Knight Jr — Geschäftsführer

Registered purpose

Der Zweck der Gesellschaft im In- und/oder Ausland ist: (i) die Erforschung, die Entwicklung, die Herstellung und die Vermarktung, einschliesslich des Ankaufs, des Verkaufs, des Imports, des Exports und des Vertriebs von Produkten aller Art und der Erbringung von Dienstleistungen aller Art in den Bereichen Pharma, Biotechnologie, Chemie, Ernährung und verwandten Gebieten sowie die Durchführung von…

🔒 Website🔒 Employees🔒 Revenue estimate

Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026

What Crinetics Pharmaceuticals Europe does

OFFERING

Crinetics Pharmaceuticals focuses on developing therapies for endocrine diseases. Their pipeline includes Paltusotine, an oral SST2 agonist, Atumelnant, an oral ACTH antagonist, and CRN09682, a non-peptide drug conjugate.

Unlock the full analysis →

Similar companies

Find every pharmaceuticals company in Switzerland

Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.

family-owned pharmaceuticals companies with 50+ employees…Search →

Full profiles from CHF 49/month · Cancel anytime